| review article | Q7318358 |
| scholarly article | Q13442814 |
| P5530 | Altmetric DOI | 10.1097/J.PAIN.0000000000000088 |
| P6179 | Dimensions Publication ID | 1028728113 |
| P356 | DOI | 10.1097/J.PAIN.0000000000000088 |
| P698 | PubMed publication ID | 25985142 |
| P5875 | ResearchGate publication ID | 273490157 |
| P1154 | Scopus EID | 2-s2.0-84945257651 |
| P50 | author | Sheena Derry | Q28036347 |
| Philip J Wiffen | Q28036553 | ||
| Christopher Eccleston | Q38327207 | ||
| Sebastian Straube | Q43144459 | ||
| Robert Andrew Moore | Q56192531 | ||
| Simon Haroutounian | Q56435682 | ||
| Ian Gilron | Q87690248 | ||
| Rae Jean Proeschold-Bell | Q90073384 | ||
| Kate Seers | Q90484674 | ||
| Scott A Strassels | Q117285407 | ||
| P2093 | author name string | Stephen Morley | |
| Ralf Baron | |||
| Arthur G Lipman | |||
| Paul M Peloso | |||
| Andrea D Furlan | |||
| Nathaniel P Katz | |||
| Steve N Quessy | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic pain | Q1088113 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 1382-1395 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | Pain | Q2317902 |
| P1476 | title | Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting | |
| P478 | volume | 156 |
| Q92259488 | Acupuncture for the Relief of Chronic Pain: A Synthesis of Systematic Reviews |
| Q89165227 | Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT |
| Q49852528 | Combination pharmacotherapy for the treatment of fibromyalgia in adults |
| Q39388226 | Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review. |
| Q97569951 | Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia |
| Q90472089 | Designing and conducting proof-of-concept chronic pain analgesic clinical trials |
| Q55135338 | Effectiveness of fixed-site high-frequency transcutaneous electrical nerve stimulation in chronic pain: a large-scale, observational study. |
| Q41466780 | Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study |
| Q54996859 | Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials. |
| Q60922407 | Evidence-Based Pain Management: Building on the Foundations of Cochrane Systematic Reviews |
| Q60646434 | Exploring psychological mechanisms of clinical response to an internet-delivered psychological pain management program |
| Q34542356 | Fentanyl for neuropathic pain in adults. |
| Q34557703 | Gabapentin for chronic neuropathic pain in adults. |
| Q39043205 | Gabapentin for fibromyalgia pain in adults |
| Q34520597 | High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications. |
| Q26471921 | Hydromorphone for neuropathic pain in adults |
| Q90158308 | Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain |
| Q28086970 | Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review |
| Q38771530 | Morphine for chronic neuropathic pain in adults. |
| Q38871845 | Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. |
| Q26470985 | Oxycodone for neuropathic pain in adults |
| Q64356942 | Pregabalin for neuropathic pain in adults |
| Q34541472 | Pregabalin for pain in fibromyalgia in adults |
| Q38755536 | Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. |
| Q90472068 | Special considerations in conducting clinical trials of chronic pain management interventions in children and adolescents and their families |
| Q28069535 | The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use |
| Q50745917 | The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain. |
| Q48311144 | The effects of treatment failure generalize across different routes of drug administration. |
| Q26765263 | The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence |
| Q38724793 | Tramadol for neuropathic pain in adults. |
Search more.